| P50 | author | Scott Kopetz | Q51789838 |
| | Giuseppe Zimmitti | Q83223562 |
| | Junichi Shindoh | Q96186003 |
| P2093 | author name string | Jean-Nicolas Vauthey | |
| | Steven A Curley | |
| | Chusilp Charnsangavej | |
| | Dipen M Maru | |
| | Thomas A Aloia | |
| | Yun Shin Chun | |
| | Piyaporn Boonsirikamchai | |
| | Evelyne M Loyer | |
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| | Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey | Q30004207 |
| | Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 |
| | Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? | Q33921511 |
| | Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases | Q34070129 |
| | Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system | Q34259566 |
| | Trends in long-term survival following liver resection for hepatic colorectal metastases | Q34523502 |
| | Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival | Q34551117 |
| | Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases | Q34557044 |
| | Liver imaging. A surgeon's perspective | Q34588187 |
| | Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. | Q34590731 |
| | Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial | Q34614245 |
| | Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy | Q35607802 |
| | Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. | Q37303627 |
| | Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan | Q37594926 |
| | The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy | Q43512983 |
| | Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. | Q44590859 |
| | Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? | Q45166892 |
| | Perioperative chemotherapy for resectable hepatic metastases | Q46688573 |
| | Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107. | Q46817228 |
| | KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab | Q46903224 |
| | Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases | Q49186620 |
| | Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. | Q53444980 |
| | Clinical Scoring Systems for Stratifying Risk after Resection of Hepatic Colorectal Metastases: Still Relevant? | Q57823440 |
| | Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie | Q71018196 |
| | Liver imaging. A surgeon's perspective | Q74375288 |
| | Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases | Q78860266 |
| | Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery | Q79294401 |
| | Hepatic resection for colorectal metastases: value for risk scoring systems? | Q80713651 |
| | Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? | Q80980181 |
| | Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out | Q83194013 |
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preoperative chemotherapy | Q108532530 |
| P304 | page(s) | 4566-4572 | |
| P577 | publication date | 2012-11-13 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases | |
| P478 | volume | 30 | |